Neulogy Ventures - aVenture Asset Manager Research
Location
Bratislava, Bratislava Region, SK
Founded
2013
Neulogy Ventures is a Bratislava-based venture capital firm focusing on seed and Series A investments in deeptech startups leveraging Central and Eastern European engineering talent. The firm targets moonshot ideas pushing technological boundaries in areas such as climate and health, with a commitment to real innovation rather than following trends.
Notable portfolio companies include Anvesana, which develops RNAseq analysis platforms for rare genetic disorders, Diagnose.me, a digital platform for international medical diagnoses, and MultiplexDX, which has raised $1.2 million. Neulogy Ventures emphasizes a professional, transparent, and hands-on approach to working with both portfolio companies and investors, aiming to help entrepreneurs build globally successful companies.
Neulogy Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Follow-on Investments5
Current Portfolio Count3
Top Investment Stages
Seed3 (100.0%)
Stage Mix
Seed 100%
Concentration shown as share of disclosed investments by stage.